Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Marti

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|March 24, 2023
A multiplex inhalation platform to model <i>in situ</i> like aerosol delivery in a breathing lung-on-chipArunima Sengupta, Aurélien Dorn, Mohammad Jamshidi, et al.
Cell Death and Differentiation|December 6, 2024
Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancerLiang Zhao, Haibin Deng, Jingyi Zhang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 30, 2020
EpCAM<sup>+</sup>CD73<sup>+</sup> mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinomaLimei Wang, Patrick Dorn, Cedric Simillion, et al.
Clinical and Translational Medicine|March 31, 2025
Transitional CXCL14<sup>+</sup> cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinomaWeijiao Xu, Haitang Yang, Ke Xu, et al.
EMBO Molecular Medicine|August 9, 2021
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancerZhang Yang, Shun-Qing Liang, Maria Saliakoura, et al.
Oncoimmunology|February 14, 2022
Functional and molecular characterization of PD1<sup>+</sup> tumor-infiltrating lymphocytes from lung cancer patientsJesse J Lipp, Limei Wang, Haitang Yang, et al.
Cell Death Discovery|February 10, 2023
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesotheliomaHaitang Yang, Yanyun Gao, Duo Xu, et al.
Oncogene|September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancerShun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
Plos Pathogens|July 28, 2021
Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infectionMelanie Brügger, Thomas Démoulins, G Tuba Barut, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
CD90<sup>+</sup>CD146<sup>+</sup> identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lungLimei Wang, Patrick Dorn, Soheila Zeinali, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|March 24, 2023
A multiplex inhalation platform to model <i>in situ</i> like aerosol delivery in a breathing lung-on-chipArunima Sengupta, Aurélien Dorn, Mohammad Jamshidi, et al.
Cell Death and Differentiation|December 6, 2024
Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancerLiang Zhao, Haibin Deng, Jingyi Zhang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 30, 2020
EpCAM<sup>+</sup>CD73<sup>+</sup> mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinomaLimei Wang, Patrick Dorn, Cedric Simillion, et al.
Clinical and Translational Medicine|March 31, 2025
Transitional CXCL14<sup>+</sup> cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinomaWeijiao Xu, Haitang Yang, Ke Xu, et al.
EMBO Molecular Medicine|August 9, 2021
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancerZhang Yang, Shun-Qing Liang, Maria Saliakoura, et al.
Oncoimmunology|February 14, 2022
Functional and molecular characterization of PD1<sup>+</sup> tumor-infiltrating lymphocytes from lung cancer patientsJesse J Lipp, Limei Wang, Haitang Yang, et al.
Cell Death Discovery|February 10, 2023
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesotheliomaHaitang Yang, Yanyun Gao, Duo Xu, et al.
Oncogene|September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancerShun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
Plos Pathogens|July 28, 2021
Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infectionMelanie Brügger, Thomas Démoulins, G Tuba Barut, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
CD90<sup>+</sup>CD146<sup>+</sup> identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lungLimei Wang, Patrick Dorn, Soheila Zeinali, et al.
Pageof 6